19.10.2022 - CLEVELAND, Oct. 19, 2022 (GLOBE NEWSWIRE) - Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced .
Sotera-health
Sotera-health-company-nasdaq
Presentation-events-sotera-health
Health-company
Published: May 10, 2021
CANTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) Organogenesis Inc (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the appointment of Jon Giacomin to the Company’s Board of Directors, effective May 7, 2021. The Company also announced that Wayne Mackie resigned as a member of the Company’s Board of Directors effective May 7, 2021. Mr. Mackie’s resignation was not due to any disagreement with the Company on any matter relating to its operations, policies or practices.
“Jon is a proven leader who brings significant expertise from a nearly 30-year career in the healthcare sector,” said Gary S. Gillheeney, Sr., President and Chief Executive Officer of Organogenesis. “We believe his demonstrated capabilities in leading large, diversified healthcare businesses make him an i
China
Canton
Jon-giacomin
Lori-freedman
Mike-piccinino
Garys-gillheeney
Wayne-mackie
University-of-notre-dame
Organogenesis-holding
Cardinal-health-inc
Organogenesis-holdings-inc
Griffith-micro-science-international-inc